Filing Details

Accession Number:
0001213900-14-005321
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-01 21:30:56
Reporting Period:
2014-07-30
Filing Date:
2014-08-01
Accepted Time:
2014-08-01 21:30:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI Pharmaceutical Preparations (2834) 263931704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591256 Andreas Hadjimichael Simou Menardou 8,
Ria Court 8, Office 101
6015 Larnaca G4
No No Yes No
1591257 Amalia Hadjimichael Simou Menardou 8,
Ria Court 8, Office 101
6015 Larnaca G4
No No Yes No
1591275 Marcin Czernik Simou Menardou 8,
Ria Court 8, Office 101
6015 Larnaca G4
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-07-30 21,570 $36.20 3,121,903 No 4 S Indirect See Footenotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footenotes
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $36.00 to $36.77, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. Shares of Common Stock are owned directly by Plio Limited ("Plio"), which holds less than 10% of the outstanding Common Stock of the issuer. Plio's directors, Marcin Czernik, Andreas Hadjimichael and Amalia Hadjimichael, may be deemed to share voting and investment power and beneficial ownership of the shares of Common Stock directly owned by Plio. Gregory Jankilevitsch , the sole shareholder of Plio, may also be deemed to share voting and investment power and beneficial ownership of the shares of Common Stock directly owned by Plio. The shares owned by Plio do not include the 10,228,079 shares of the issuer's Common Stock held by Chione Limited, which has the same directors as Plio.
  3. Each reporting person states that neither the filing of this Form 4 nor anything herein shall be deemed an admission that such person or any other person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Act"), or otherwise, the beneficial owner of any securities covered by this Form 4. Beneficial ownership of the securities covered by this statement is disclaimed, except, with respect to any person, to the extent of the pecuniary interest of such person in such securities.
  4. Each reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Act. Each reporting person declares that neither the filing of this Form 4 nor anything herein shall be construed as an admission that such person or any other person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.